BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO)

On: April 26, 2026, 11:24 am EDT

URL has been copied successfully!

Share this story:

Previous Post:Insteel Industries (IIIN) Sits Comfortably With Current Market Position, Following Q2 Announcement

Next Post:Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD)